Prasugrel (Prasco Laboratories)


Welcome to the PulseAid listing for the Prasugrel drug offered from Prasco Laboratories. This Decreased Platelet Aggregation [PE],P2Y12 Platelet Inhibitor [EPC],P2Y12 Receptor Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Prasco Laboratories
NON-PROPRIETARY NAME: Prasugrel hydrochloride
SUBSTANCE NAME: PRASUGREL HYDROCHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Decreased Platelet Aggregation [PE],P2Y12 Platelet Inhibitor [EPC],P2Y12 Receptor Antagonists [MoA]
ROUTE: ORAL
DOSAGE FORM: TABLET, FILM COATED
MARKETING CATEGORY NAME: NDA AUTHORIZED GENERIC
START MARKETING DATE: 2017-08-15
END MARKETING DATE: 0000-00-00


Prasugrel HUMAN PRESCRIPTION DRUG Details:

Item DescriptionPrasugrel from Prasco Laboratories
LABELER NAME: Prasco Laboratories
DEA SCHEDULE:
ACTIVE STRENGTH: 5(mg/1)
START MARKETING DATE: 2017-08-15
END MARKETING DATE: 0000-00-00
PRODUCT ID: 66993-575_025a28e2-e7ed-4855-aa54-f1cb79dc13d5
PRODUCT NDC: 66993-575
APPLICATION NUMBER: NDA022307

Other PRASUGREL HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Apotex Corp.Prasugrel
Ascend Laboratories, LLCPRASUGREL
Aurobindo Pharma LimitedPrasugrel
Cardinal HealthEffient
Eli Lilly and CompanyEffient
Mylan Pharmaceuticals Inc.Prasugrel
Panacea Biotec Ltd.Prasugrel
Physicians Total Care, Inc.Effient
Prasco LaboratoriesPrasugrel